Related Experiment Videos
Indications and selection of patients for coronary artery bypass graft surgery
Insights
Coronary Artery Bypass Graft (CABG) surgery effectively relieves symptoms in most chronic stable angina patients. However, its benefits are less clear for unstable angina, Printzmetal angina, and ventricular fibrillation survivors, with debated impact on overall life expectancy.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Cardiac Health
Background:
- Coronary Artery Bypass Graft (CABG) is a common surgical intervention for ischemic heart disease.
- Patient outcomes following CABG vary significantly depending on the underlying cardiac condition.
- The efficacy of CABG in specific patient subgroups remains an area of active investigation.
Purpose of the Study:
- To evaluate the effectiveness of CABG in different angina classifications.
- To assess the impact of CABG on symptom relief and long-term survival.
- To clarify the indications and contraindications for CABG surgery.
Main Methods:
- Review of patient outcomes following CABG for chronic stable angina.
- Analysis of data for patients with unstable angina, Printzmetal angina, and post-ventricular fibrillation.
- Examination of CABG's role in acute myocardial infarction and its impact on longevity.
Main Results:
- Approximately 75% of patients with chronic stable angina are asymptomatic one year post-CABG.
- Indications for CABG in unstable angina are not clearly defined.
- CABG has not demonstrated benefit in Printzmetal angina or survivors of ventricular fibrillation.
- CABG for acute myocardial infarction presents a contentious issue with reported operative mortality of 5.2%.
- Improved longevity is evident in patients with left main and triple vessel disease.
Conclusions:
- CABG is highly effective for symptom relief in chronic stable angina.
- The utility of CABG is questionable in specific conditions like Printzmetal angina and post-ventricular fibrillation.
- CABG's role in acute myocardial infarction requires further clarification.
- Significant survival benefits are observed in left main and triple vessel disease patients undergoing CABG.
Abstract:
Patients with chronic stable angina who have coronary artery bypass graft (CABG) surgery for the relief of symptoms are asymptomatic after one year in about 75% of cases. The indications for surgery in unstable angina are unclear. CABG has not shown to benefit patients with Printzmetal angina or who survived an episode of ventricular fibrillation. CABG for acute myocardial infarction is a contentious issue, buy an operative death rate of 5.2% with a late mortality of 1.1% has been reported. There is still debate about the usefulness of CABG in promoting life expectancy. Improved longevity is clearly seen in left main and triple vessel disease.